Nebulizers in pediatric age: domiciliary use in São Miguel
DOI:
https://doi.org/10.32385/rpmgf.v38i4.13167Keywords:
Nebulizers and vaporizers, Domicile, PediatricsAbstract
Introduction: Respiratory diseases are a major cause of morbidity in the pediatric population. Nebulizers, for years the most suitable devices for administering aerosol therapy in children, have been superseded by simple inhalation devices. Current clinical guidelines restrict the prescription and use of nebulizers. The study aims to investigate the reality of domiciliary use of nebulizing systems in the pediatric age in the São Miguel Island Health Unit.
Methods: Observational, analytical, and cross-sectional study. Inclusion criteria: children from zero to seven years and 365 days of age. A face-to-face survey was performed on caregivers of the target population to assess the context of the acquisition, use, and maintenance of nebulizers. A significant sample of 380 users was calculated (95% confidence interval).
Results: Participation of 387 caregivers. The average age of children included 2.5 years. 45,7% of participants had a nebulizer and 18,9% reported having a simple inhaler device. The rate of acquisition and use of nebulizers without medical prescription was 67.8% and 79.7%, respectively. The cost of acquiring the nebulization system was between 80 and 150 euros for 38.4% of the participants. Most of the unsupervised use occurred with saline and in the context of nasal obstruction (41.1%) and cough (24.9%).
Discussion: The present study reveals an excessive, unsupervised and inappropriate use of nebulizers in pediatric age. The present investigation should encourage the promotion of the use of simple inhaler devices, by educating users, caregivers, and health professionals, aiming to improve local health practice.
Downloads
References
Forum of International Respiratory Societies. The global impact of respiratory disease [Internet]. 2nd ed. Sheffield: European Respiratory Society; 2017. Available from: https://static.physoc.org/app/uploads/2019/04/22192917/The_Global_Impact_of_Respiratory_Disease.pdf
Zar HJ, Ferkol TW. The global burden of respiratory disease: impact on child health. Pediatr Pulmonol. 2014;49(5):430-4.
Borghardt JM, Kloft C, Sharma A. Inhaled therapy in respiratory disease: the complex interplay of pulmonary kinetic processes. Can Respir J. 2018;2018:2732017.
Direção-Geral da Saúde. Cuidados respiratórios domiciliários: prescrição de aerossolterapia por sistemas de nebulização: norma nº 021/2011, de 28/09/2011, atualizada em 11/09/2015. Lisboa: DGS; 2015.
Boe J, Dennis JH, O'Driscoll BR, Bauer TT, Carone M, Dautzenberg B, et al. European Respiratory Society guidelines on the use of nebulizers. Eur Respir J. 2001;18(1):228-42.
Direção-Geral da Saúde. Utilização de dispositivos simples em aerossolterapia: orientação nº 010/2013, de 02/08/2013, atualizada em 18/12/2013. Lisboa: DGS; 2013.
Direção-Geral da Saúde. COVID-19 – Fase de mitigação: cuidados de reabilitação e respiratórios domiciliários: orientação nº 020/2020, de 03/04/2020. Lisboa: DGS; 2020.
Boyter AC, Carter R. How do patients use their nebuliser in the community? Respir Med. 2005;99(11):1413-7.
Butz AM, Eggleston P, Huss K, Kolodner K, Rand C. Nebuliser use in inner-city children with asthma: morbidity, medication use, and asthma management practices. Arch Pediatr Adolesc Med. 2000;154(10):984-90.
Oliveira G, Neto T, Dias C, Oliveira C, Aguiar AP, Rodrigues C, et al. Uso e abuso dos nebulizadores no domicílio [Use and abuse of home-use nebulizers]. Acta Pediatr Port. 2005;36(6):290-6. Portuguese
Direção-Geral da Saúde. Diagnóstico e tratamento da bronquiolite aguda em idade pediátrica: norma nº 016/2012, de 19/12/2012, atualizada em 23/02/2015. Lisboa: DGS; 2015.
Cohen HA, Kahan E, Cohen Z, Sarrel M, Beni S, Grosman Z, et al. Microbial colonization of nebulizers used by asthmatic children. Pediatr Int. 2006;48(5):454-8.
Jarvis S, Ind PW, Thomas C, Goonesekera S, Haffenden R, Abdolrasouli A, et al. Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease. BMJ Open Respir Res. 2014;1(1):e000018.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Portuguese Journal of Family Medicine and General Practice
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.
